Furnizare Medicamente - Antineoplazice I /7 Loturi .

Deadline:19 Jun 2026, 12:00

Tender information
Romania
Constanţa
Type
Contract
Procedure
Open procedure
Ref. number
4301103-336E
Estimated value
RON 19,242,295.50
Contract type
Framework agreement
Duration
24 months
FURNIZARE MEDICAMENTE Pembrolizumabum 100 mg Ipilimumabum 200 mg Ipilimumabum 50 mg Avelumabum 200 mg Irinotecanum 4.3 mg/ml Cemiplimabum 350 mg/7 ml (50 mg/ml) Tenecteplazum 25 mg pulb. pt. sol. inj. (Metalyse 5000 U)

Pembrolizumabum 100 mg

Pembrolizumabum 100 mg flacon

Ipilimumabum 200 mg

Ipilimumabum 200 mg flacon

Ipilimumabum 50 mg

Ipilimumabum 50 mg flacon

Avelumabum 200 mg

Avelumabum 200 mg flacon

Irinotecanum 4.3 mg/ml

Irinotecanum 4.3 mg/ml flacon

Cemiplimabum 350 mg/7 ml (50 mg/ml)

Cemiplimabum 350 mg/7 ml (50 mg/ml) flacon

Tenecteplazum 25 mg pulb. pt. sol. inj. (Metalyse 5000 U)

Tenecteplazum 25 mg pulb. pt. sol. inj. (Metalyse 5000 U) flacon

Buyer
SPITALUL CLINIC JUDETEAN DE URGENTA SF. APOSTOL ANDREI
buyer-email@mail.com
organization number

Documents

Document name
Upload date
File size
First document.pdf
1 Jan 1970, 00:001 Bytes
Second document.pdf
1 Jan 1970, 00:001 Bytes
Open for offers
2 days left
Important dates
18 May - Publication date
19 Jun - Deadline
Unlock Full Access with Mercell Bidding Business Plus
Start your free trial to explore exclusive features that help you win more tenders, faster:
AI-Powered Tender Insights
Buyer Contact Info
Key Tender Timelines

Already have an account?

Mercell Logo

Feel free to reach out!

Mercell is the leading European provider of e-tendering and procurement systems, and information between buyers and suppliers in the professional market.

We appreciate your input.

© Mercell Group 2026

Terms & Conditions and Privacy Notice

Mercell Group

  • Email: post@mercell.com
  • Phone: +47 21 01 88 00
  • Address: Askekroken 11, 0277 Oslo, Norway

Your privacy is important to us

We use cookies to improve your experience and evaluate each item on our site. By clicking further, you accept our use of cookies.